These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6831038)

  • 1. Spontaneous hematologic recovery from bone marrow aplasia after accidental tenfold overdosage with radiophosphorus.
    Gmür J; Bischof B; Coninx S; Bucher U; Poretti G; Henrichs K; Kaul A; Roedler HD; Büttner K; Frick PG
    Blood; 1983 Apr; 61(4):746-50. PubMed ID: 6831038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiophosphorus therapy of polycythemia vera].
    Hör G; Pabst HW
    Ther Umsch; 1973 Nov; 30(11):789-96. PubMed ID: 4591693
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term follow-up of a patient with accidental phosphor 32 overdose].
    Holy D; Caduff B; Kistler HJ
    Schweiz Med Wochenschr; 1994 Oct; 124(42):1848-51. PubMed ID: 7973511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiophosphorus (32P) treatment of bone marrow disorders in dogs: 11 cases (1970-1987).
    Smith M; Turrel JM
    J Am Vet Med Assoc; 1989 Jan; 194(1):98-102. PubMed ID: 2914806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
    Parmentier C; Gardet P
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy.
    Wilder RB; DeNardo GL; Sheri S; Fowler JF; Wessels BW; DeNardo SJ
    Eur J Nucl Med; 1996 Aug; 23(8):953-7. PubMed ID: 8753685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group.
    Najean Y; Rain JD
    Blood; 1997 Apr; 89(7):2319-27. PubMed ID: 9116275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
    Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Remission incidence and adverse effects in low-dosage radioactive phosphorus therapy of polycythemia vera].
    Hauswaldt C; Horejschi J; Emrich D; Heckner F; Douwes FW; Ziesemer G
    Verh Dtsch Ges Inn Med; 1975; 81():1128-30. PubMed ID: 1229414
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peroral 32P in polycythemia vera and essential thrombocytopenia. An old method still of current interest].
    Brandt L; Anderson H
    Lakartidningen; 1995 Aug; 92(34):2989-92. PubMed ID: 7650986
    [No Abstract]   [Full Text] [Related]  

  • 11. The absorbed dose to bone marrow in the treatment of polycythaemia by 32P.
    Spiers FW; Beddoe AH; King SD
    Br J Radiol; 1976 Feb; 49(578):133-40. PubMed ID: 938829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients.
    Siegel JA; Yeldell D; Goldenberg DM; Stabin MG; Sparks RB; Sharkey RM; Brenner A; Blumenthal RD
    J Nucl Med; 2003 Jan; 44(1):67-76. PubMed ID: 12515878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 32P-therapy in polycythemia vera.
    Meuret G; Hoffmann G; Gmelin R
    Klin Wochenschr; 1975 Jun; 53(11):519-21. PubMed ID: 807769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment by radiophosphorus versus busulfan in polycythemia vera: a randomized trial (E.O.R.T.C.'s) "leukemias and hematosarcomas" group.
    Recent Results Cancer Res; 1977; (62):104-9. PubMed ID: 341245
    [No Abstract]   [Full Text] [Related]  

  • 16. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
    Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
    J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
    Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of the blood lymphocyte subpopulations and their functions following 131I treatment for nodular goitre and 32P treatment for polycythemia vera.
    Wasserman J; Blomgren H; Petrini B; Svedmyr E; Schnell PO; Lundell G; Von Stedingk LV
    Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Jan; 53(1):159-67. PubMed ID: 3257474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematology clinics. II. The treatment of polycythemia vera with radiophosphorus.
    NORCROSS JW; WARD CL
    Lahey Clin Bull; 1959; 11():155-9. PubMed ID: 14427558
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple myeloma on polycythemia vera following radioactive phosphorus therapy.
    West WO
    South Med J; 1976 Nov; 69(11):1516-7. PubMed ID: 1019658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.